Volume 139, Issue 1, Pages e7 (July 2010)

Slides:



Advertisements
Similar presentations
Volume 137, Issue 4, Pages e8 (October 2009)
Advertisements

Volume 142, Issue 4, Pages (April 2012)
Volume 135, Issue 5, Pages (November 2008)
Volume 16, Issue 5, Pages (November 2012)
Volume 139, Issue 4, Pages e4 (October 2010)
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 136, Issue 1, Pages e2 (January 2009)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 133, Issue 5, Pages (November 2007)
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Volume 132, Issue 4, Pages (April 2007)
Volume 144, Issue 7, Pages e10 (June 2013)
Volume 133, Issue 6, Pages (December 2007)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 127, Issue 5, Pages (November 2004)
Volume 146, Issue 5, Pages e1 (May 2014)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 133, Issue 6, Pages (December 2007)
Volume 64, Issue 1, Pages (January 2016)
Volume 123, Issue 4, Pages (October 2002)
Volume 137, Issue 4, Pages e5 (October 2009)
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 129, Issue 5, Pages (November 2005)
Volume 141, Issue 4, Pages e5 (October 2011)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Volume 126, Issue 5, Pages (May 2004)
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Volume 42, Issue 4, Pages (April 2005)
Volume 143, Issue 3, Pages e3 (September 2012)
Volume 138, Issue 2, Pages e1 (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 142, Issue 4, Pages (April 2012)
Volume 132, Issue 7, Pages (June 2007)
Volume 136, Issue 4, Pages (April 2009)
Volume 139, Issue 1, Pages e6 (July 2010)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 132, Issue 5, Pages (May 2007)
Volume 141, Issue 1, Pages (July 2011)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 143, Issue 1, Pages e7 (July 2012)
T Cell-Derived Lymphotoxin Regulates Liver Regeneration
Volume 135, Issue 5, Pages (November 2008)
Volume 17, Issue 1, Pages (January 2010)
Volume 16, Issue 5, Pages (November 2012)
Obesity, Inflammation, and Insulin Resistance
Volume 142, Issue 1, Pages e10 (January 2012)
Volume 129, Issue 1, Pages (July 2005)
Volume 135, Issue 3, Pages e3 (September 2008)
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Volume 134, Issue 4, Pages (April 2008)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 126, Issue 3, Pages (March 2004)
Volume 125, Issue 1, Pages (July 2003)
Volume 135, Issue 4, Pages (October 2008)
Volume 16, Issue 1, Pages (July 2012)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 136, Issue 3, Pages (March 2009)
Volume 120, Issue 2, Pages (February 2001)
Volume 128, Issue 1, Pages (January 2005)
Volume 17, Issue 1, Pages (January 2010)
Volume 144, Issue 5, Pages e4 (May 2013)
Volume 132, Issue 2, Pages (February 2007)
Volume 61, Issue 6, Pages (December 2014)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 24, Issue 6, Pages (December 2016)
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma  Myoung Sook Han, Tamera Barrett, Michael.
Presentation transcript:

Volume 139, Issue 1, Pages 323-334.e7 (July 2010) Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice  Kouichi Miura, Yuzo Kodama, Sayaka Inokuchi, Bernd Schnabl, Tomonori Aoyama, Hirohide Ohnishi, Jerrold M. Olefsky, David A. Brenner, Ekihiro Seki  Gastroenterology  Volume 139, Issue 1, Pages 323-334.e7 (July 2010) DOI: 10.1053/j.gastro.2010.03.052 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 TLR9 deficiency attenuates steatohepatitis. WT and TLR9−/− mice were fed a CSAA (CS; n = 4) or CDAA (CD; n = 8) diet for 22 weeks. Closed bar, WT mice; open bar, TLR9−/− mice. (A) Liver sections were stained with H&E (arrowheads, inflammatory cells; arrows, ballooning hepatocytes), Oil-Red O, TUNEL (arrows; apoptotic cells), and Sirius red. Original magnification, ×200 for H&E and TUNEL staining, ×100 for Oil-Red O and Sirius red stainings. (B) Number of TUNEL-positive cells, (C) Sirius red–positive area and (D) NAFLD activity score were calculated. N.D., not detected. (E) Hepatic triglyceride and serum ALT levels were measured. (F) Hepatic mRNA levels of fibrogenic markers were determined by quantitative real-time PCR. Data represent mean ± SD; *P < .05; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 TLR9 induces IL-1β production in Kupffer cells. (A and B) The livers and sera were harvested from 22-week-old CSAA (CS) or CDAA (CD) diet-fed WT, TLR9−/−, and MyD88−/− mice. (A) Hepatic mRNA levels of inflammatory cytokines were measured by quantitative real-time PCR (qPCR). (B) Serum IL-1β levels were measured by enzyme-linked immunoabsorbent assay (ELISA). (C) WT mice (21 weeks old) fed the CDAA diet were injected control (Veh; n = 6) or clodronate liposome (Clo; n = 6) to deplete Kupffer cells. The livers and sera were harvested 1 week after the liposome injection. Hepatic mRNA and serum protein levels of IL-1β were measured by qPCR and ELISA, respectively. (D) IL-1β mRNA expression in hepatocytes, Kupffer cells, HSCs, and sinusoidal endothelial cells was measured by qPCR. (E) WT, TLR9−/−, and MyD88−/− Kupffer cells were treated with 5 μg/mL CpG-ODN or non–CpG-ODN, and then IL-1β mRNA levels were measured by qPCR. To convert active IL-1β from proIL-1β, Kupffer cells were treated with 2 mmol/L ATP for 30 minutes after 24 hours of incubation with 5 μg/mL CpG-ODN (n = 4, each group), and then secreted IL-1β levels were measured by ELISA. Data represent mean ± SD; *P < .05, **P < .01; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 3 IL-1β promotes lipid metabolism and cell death in hepatocytes. (A–C) WT, TLR9−/−, and IL-1R−/− hepatocytes were treated with 10 ng/mL IL-1β. Veh, vehicle. (A) Lipid accumulation (Oil-Red O staining) and (B) triglyceride content (normalized to protein concentration) were measured in WT, TLR9−/−, and IL-1R−/− hepatocytes treated with IL-1β for 24 hours. (C) Hepatocytes were treated with IL-1β for 8 hours. mRNA expression of DGATs in hepatocytes was determined by quantitative real-time PCR (qPCR). (D–F) Hepatocytes were isolated from 22-week-old mice fed the CSAA (CS) or the CDAA (CD) diet. (D) Hepatocytes were treated with IL-1β for 24 hours. Apoptosis and necrosis were determined by Hoechst33342 and propidium iodide, respectively. (E) ALT and LDH levels in supernatant were measured. (F, left) mRNA levels of Bcl2 and Bax were determined by qPCR. (F, right) NF-κB activity in response to IL-1β was examined by NF-κB–reporter assay. Data represent mean ± SD; *P < .05, **P < .01; n.s., not significant. Original magnification, ×400 (A), ×200 (C). Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 4 Kupffer cell–derived IL-1β promotes HSC activation. (A–D) HSCs isolated from WT, TLR9−/−, and IL-1R−/− mice were stimulated with 10 ng/mL IL-1β for 8 hours to measure mRNA expression of TIMP1 (A), PAI-1 (B), collagen (C), and Bambi (D) by quantitative real-time PCR (qPCR), and for 24 hours to determine TIMP1 expression in the supernatant by Western blot (A). (E) Kupffer cell–conditioned medium (Kup-CM) was prepared by treating Kupffer cells with 5 μg/mL CpG-ODN or non–CpG-ODN for 24 hours. Then, WT, TLR9−/−, and IL-1R−/− HSCs were treated with Kup-CM for 8 hours to determine mRNA expression of fibrogenic markers by qPCR (E, left) and for 24 hours to determine TIMP1 protein expression in the supernatant (E, right). Data represent mean ± SD; *P < .05, **P < .01; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 5 IL-1R−/− mice show attenuated steatosis and fibrosis. WT and IL-1R−/− mice were fed a CSAA diet (CS; n = 4) or CDAA diet (CD; n = 8) for 22 weeks. Closed bar, WT mice; open bar, IL-1R−/− mice. (A) H&E (arrowheads, inflammatory cells; arrows, ballooning hepatocytes), Oil-Red O, TUNEL (arrows; apoptotic cells), and Sirius red staining were performed. Original magnification, ×200 for H&E and TUNEL, ×100 for Oil-Red O and Sirius red. (B) Number of TUNEL-positive cells and (C) Sirius red–positive area were suppressed in IL-1R−/− mice. (D) NAFLD activity score, steatosis, and fibrosis were suppressed in IL-1R−/− mice. N.D., not detected. (E) Hepatic triglyceride and serum ALT levels were decreased in IL-1R−/− mice. (F) Hepatic mRNA levels of fibrogenic markers were measured by quantitative real-time PCR. Data represent mean ± SD, *P < .05; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 6 Gene deletion of MyD88 ameliorates steatohepatitis. WT and MyD88−/− mice were fed a CSAA (CS, n=4) or CDAA (WT-CD, n = 8; MyD88−/−-CD, n = 7) diet for 22 weeks. Closed bar, WT mice; open bar, MyD88−/− mice. (A) H&E (arrowheads, inflammatory cells; arrows, ballooning hepatocytes), Oil-Red O, TUNEL (arrows; apoptotic cells), and Sirius red staining show reduced steatosis, inflammatory cells, apoptosis, and fibrosis in MyD88−/− mice. Original magnification, ×200 for H&E and TUNEL staining, ×100 for Oil-Red O and Sirius red stainings. (B) TUNEL-positive cells, (C) Sirius red–positive area, and (D) NAFLD activity score were suppressed in MyD88−/− mice. N.D., not detected. (E) Hepatic triglyceride and serum ALT levels were suppressed in MyD88−/− mice. (F) Hepatic mRNA levels of fibrogenic markers were determined by quantitative real-time PCR. Data represent mean ± SD; *P < .05, **P < .01; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Figure 7 (A) TLR9–MyD88–IL-1R axis promotes insulin resistance. Normal chow (N), CSAA (CS), and CDAA (CD) diets were fed to WT, TLR9−/−, IL-1R−/−, and MyD88−/− mice for 22 weeks (n = 6, each group). Insulin resistance was examined by HOMA-IR. Data represent mean ± SEM; **P < .01; n.s., not significant. (B) The proposed mechanism responsible for the development of NASH through TLR9 and IL-1β. TLR9 ligands, including bacterial DNA or other endogenous mediators, stimulate Kupffer cells to produce IL-1β. Secreted IL-1β acts on hepatocytes to increase lipid accumulation and cell death, causing steatosis and inflammation. IL-1β also stimulates HSCs to produce fibrogenic factors such as collagen and TIMP-1, resulting in fibrogenesis. Simultaneously, the TLR9-MyD88 axis promotes insulin resistance. TLR4 also contributes to this network in NASH as described previously.4 Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 1 CDAA diet-induced steatohepatitis mimics human NASH. WT mice were fed standard chow (ST, n = 6), CSAA (CS, n = 4), and CDAA (CD, n = 5) diets for 22 weeks. (A) Liver sections were stained with H&E, Oil Red O, TUNEL, and Sirius Red. Inflammatory cell infiltration (arrowheads) and ballooning hepatocytes (arrow) are seen in the CDAA diet group by H&E staining. Arrows indicate apoptotic cells in TUNEL staining. Perisinusoidal fibrosis is seen in the CDAA group by Sirius red staining. Original magnification, ×200 for H&E and TUNEL, ×100 for Oil Red O and Sirius red staining. (B) Number of TUNEL-positive cells, (C) Sirius red–positive area, and (D) NAFLD activity score were calculated. N.D, not detected. (E) Serum ALT level. (F) Hepatic mRNA levels of profibrogenic markers were determined by quantitative real-time PCR. Genes were normalized to 18S RNA as an internal control. Data represent mean ± SD; *P < .05, **P < .01; n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 2 Comparable food intake in WT and TLR9−/− mice. A CDAA diet intake was measured on WT and TLR9−/− mice. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 3 Specific deletion of Kupffer cells, but not HSCs and sinusoidal endothelial cells, by liposomal clodronate treatment. (A and B) Liver samples were harvested 24 hours after the injection of liposomal clodronate. Kupffer cells, HSCs, sinusoidal endothelial cells were determined by immunohistochemistry for F4/80 (A), desmin (B), and CD31 (C). Liposomal clodronate injection completely depleted Kupffer cells, but it did not influence the number of HSCs and sinusoidal endothelial cells. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 4 Inhibition of NF-κB activation is essential for IL-1β–induced cell death. Inactivation of NF-κB increased the susceptibility to IL-1β–induced hepatocyte cell death. NF-κB activation in hepatocytes was inhibited by adenovirus expressing IB-super-repressor (IκB-sr). Cell death (A), ALT (B), and LDH (C) levels were examined (n = 4, each group). Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 5 An effect of CpG-ODN on hepatocytes. A CpG-ODN induced neither lipid accumulation nor cell death in both normal hepatocyte (A–E) and lipid-accumulated hepatocytes (F–J). Hepatocytes were treated with 5 μg/mL CpG-ODN (C) or non–CpG-ODN (N) for 24 hours. (A and F) Oil Red O staining, (B and G) triglyceride content in hepatocytes, (C and H) cell death, (D and I) ALT, and (E and J) LDH levels in supernatant are shown (n = 4, each group). Original magnification, ×400 (A), ×200 (F). Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 6 HSCs are not activated by TLR9 ligand. (A and B) WT stellate cells were treated with 5 μg/mL CpG-ODN (C) or non–CpG-ODN (N) for 8 hours followed by measurement of mRNA expression of profibrogenic markers by quantitative real-time PCR. (B) NF-κB activity in response to IL-1β was examined by the infection of adenovirus expressing NF-κB–driven luciferase. n.s., not significant. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions

Supplementary Figure 7 Strong IRAK-M expression in hepatocytes isolated from the CDAA diet. (A and B) Hepatocytes were isolated from WT mice fed a CSAA or CDAA diet for 22 weeks. (A) IRAK-M mRNA expression was determined by quantitative real-time PCR. (B) Immunoblots of IRAK-M are shown. Significant up-regulation of IRAK-M expression in hepatocytes from mice fed the CDAA diet was observed. Gastroenterology 2010 139, 323-334.e7DOI: (10.1053/j.gastro.2010.03.052) Copyright © 2010 AGA Institute Terms and Conditions